MDM2 and colorectal cancer: Our previous study showed that LACTB inhibits colorectal cancer progression in a wild-type p53-dependent manner [24]; LACTB can directly bind to p53 protein to inhibit p53 ubiquitination degradation by preventing MDM2 from interacting with p53 [24].